Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy | Globalization and Health BioMed Central Debate Open Access Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy Thomas Faunce 1 2 Evan Doran1 3 David Henry1 4 Peter Drahos1 Andrew Searles1 3 Brita Pekarsky1 5 and Warwick Neville1 Address 1Globalisation and Health Project Centre for Governance of Knowledge and Development Regulatory Institutions Network Australian National University Acton Canberra ACT Australia 2Medical School and Law Faculty The Australian National University Acton Canberra ACT Australia 3Newcastle Institute of Public Health University of Newcastle Newcastle New South Wales Australia 4Clinical Pharmacology School of Medical Practice and Population Health University of Newcastle Newcastle New South Wales Australia and 5Centre for Regulation and Market Analysis University of South Australia Adelaide South Australia Australia Email Thomas Faunce - Evan Doran - David Henry - Peter Drahos - Andrew Searles - andrew@ Brita Pekarsky - Warwick Neville - Corresponding author Published 06 October 2005 Globalization and Health 2005 1 15 doi 1744-8603-1-15 Received 21 July 2005 Accepted 06 October 2005 This article is available from http content 1 1 15 2005 Faunce et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract On 1 January 2005 a controversial trade agreement entered into force between Australia and the United States. Though heralded by the parties as facilitating the removal of barriers to free trade in ways not achievable in .
